Profil
Abdul Khan, Ph.D., is a Director, Biologics, Deerfield Discovery and Development, and joined the Firm in 2022.
Prior to Deerfield, Dr. Khan was a Director, Protein Engineering at Molecular Templates for a year.
Before this, he was most recently Senior Associate Director, Protein and Cell Line Engineering for Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), where he worked for more than five years.
Dr. Khan holds a B.S.
in Chemistry, Zoology, and Botany, an M.S.
in Zoology, a Master of Philosophy in Molecular Biology from Punjab University, Pakistan, and a Ph.D.
in Natural Sciences from University of Vienna, Austria.
Postes actifs de Abdul Khan
| Sociétés | Poste | Début |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Directeur/Membre du Conseil | 01/09/2022 |
Anciens postes connus de Abdul Khan
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur/Membre du Conseil | 01/09/2022 |
Formation de Abdul Khan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Punjab
University of the Punjab Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
















